ADALTA LIMITED - Announcements

0.00%

0.3¢

Market Cap $3.338M

Healthcare Biotechnology

AdAlta Limited is an Australia-based clinical-stage biotechnology company. The Company... AdAlta Limited is an Australia-based clinical-stage biotechnology company. The Company uses its i-body platform to discover and develop protein therapeutics addressing drug targets that are challenging for other technologies. The Company's first-in-class lead asset, AD-214, is being developed for the treatment of idiopathic pulmonary fibrosis (IPF) and other fibrotic diseases, for which current therapies are sub-optimal. AD-214 is an Fc-Fusion protein that contains two AD-114 i-body molecules at the front end, that bind with high affinity to the human target, CXCR4. It is also engaged in developing i-body enabled Chimeric antigen receptor T cell (CAR-T) cells. It co-develops i-bodies as diagnostic imaging agents (i-PET imaging) against Granzyme B, a biomarker of response to immuno-oncology drugs.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

Announcements

Filter Results

All Price Sensitive Only

1AD	1AD Investor Presentation		30/07/25	2.24MB	Share
1AD	Notification of cessation of securities - 1AD		28/07/25	15.33KB	Share
1AD	Quarterly Appendix 4C and Activities Report	PRICE SENSITIVE	23/07/25	454.87KB	Share
1AD	Cleansing Notice		11/07/25	326.43KB	Share
1AD	Application for quotation of securities - 1AD		11/07/25	15.9KB	Share
1AD	Final Director's Interest Notice		02/07/25	3.22KB	Share
1AD	Board Change		30/06/25	184.86KB	Share
1AD	Change in Director Interest Notice (IR & DF)		13/06/25	316.74KB	Share
1AD	Application for quotation of securities - 1AD		13/06/25	16.99KB	Share
1AD	Application for quotation of securities - 1AD		13/06/25	16.37KB	Share
1AD	Renounceable Rights Issue shortfall placed	PRICE SENSITIVE	13/06/25	230.62KB	Share
1AD	Change in Director Interest Notice (TO, PM, IR & DF)		11/06/25	535.75KB	Share
1AD	Change in substantial holding		05/06/25	164.28KB	Share
1AD	Top 20 Option Holders & Distribution Schedule		04/06/25	85.24KB	Share
1AD	Application for quotation of securities - 1AD		04/06/25	16.42KB	Share
1AD	Application for quotation of securities - 1AD		04/06/25	17.02KB	Share
1AD	Rights Issue raises $1.1million	PRICE SENSITIVE	03/06/25	225.72KB	Share
1AD	Notice of change of exercise price of options	PRICE SENSITIVE	28/05/25	290.43KB	Share
1AD	New AD-214 publication		22/05/25	273.42KB	Share
1AD	Investor webinar invitation		19/05/25	209.2KB	Share
1AD	Investor Presentation		07/05/25	2MB	Share
1AD	COMMENCEMENT OF RIGHTS TRADING		07/05/25	192.81KB	Share
1AD	Update - Proposed issue of securities - 1AD		05/05/25	25.67KB	Share
1AD	Letter to Foreign Shareholders		05/05/25	254.87KB	Share
1AD	Letter to Optionholders		05/05/25	283.5KB	Share
1AD	Target Market Determination		05/05/25	188.07KB	Share
1AD	Update - Proposed issue of securities - 1AD		05/05/25	25.52KB	Share
1AD	Prospectus	PRICE SENSITIVE	05/05/25	1.02MB	Share
1AD	Change of registered address		02/05/25	185.62KB	Share
1AD	Proposed issue of securities - 1AD		01/05/25	25.77KB	Share
1AD	Renounceable Rights Issue to Raise up to $1.3 million	PRICE SENSITIVE	01/05/25	231.96KB	Share
1AD	Quarterly Appendix 4C and Activities Report	PRICE SENSITIVE	01/05/25	284.08KB	Share
1AD	Trading Halt	PRICE SENSITIVE	30/04/25	294.32KB	Share
1AD	Notification regarding unquoted securities - 1AD		14/04/25	15.53KB	Share
1AD	Notification of cessation of securities - 1AD		14/04/25	12.75KB	Share
1AD	ASX Emerging Gems presentation		26/03/25	197.05KB	Share
1AD	SYNBV invest up to $2m in East to West subsidiary	PRICE SENSITIVE	20/03/25	267.11KB	Share
1AD	Cleansing Notice		17/03/25	294.25KB	Share
1AD	Application for quotation of securities - 1AD		17/03/25	15.86KB	Share
1AD	Investor presentation - Stocks on Track		13/03/25	1.17MB	Share
1AD	R&D Tax Incentive advance received	PRICE SENSITIVE	05/03/25	225KB	Share
1AD	Company presentation - East-West Biopharma Summit		04/03/25	1.67MB	Share
1AD	Cleansing Notice		21/02/25	229.94KB	Share
1AD	Application for quotation of securities - 1AD		21/02/25	15.67KB	Share
1AD	Half Yearly Report and Accounts	PRICE SENSITIVE	20/02/25	1.53MB	Share
1AD	Webinar presentation - East to West cell therapy strategy		11/02/25	754.42KB	Share
1AD	Cleansing Notice		07/02/25	155.72KB	Share
1AD	Application for quotation of securities - 1AD		07/02/25	15.67KB	Share
1AD	Investor Presentation	PRICE SENSITIVE	07/02/25	1.84MB	Share
1AD	Investor webinar: East to West cell therapy strategy		06/02/25	198KB	Share
1AD	East to West cell therapy strategy update	PRICE SENSITIVE	06/02/25	566.55KB	Share
1AD	AdAlta presenting at 3rd ANZ Biologics Festival		04/02/25	2.21MB	Share
1AD	Quarterly Appendix 4C and Activities Report	PRICE SENSITIVE	31/01/25	414.13KB	Share
1AD	Notification regarding unquoted securities - 1AD		13/01/25	16.05KB	Share
1AD	Investor Presentation	PRICE SENSITIVE	10/01/25	2.31MB	Share
1AD	Change of Director's Interest Notice (TO)		05/12/24	296.98KB	Share
1AD	Notification regarding unquoted securities - 1AD		05/12/24	19.82KB	Share
1AD	Presentation at ASCEPT, APFP & APSA Joint Congress		02/12/24	3.73MB	Share
1AD	Investor Presentation		21/11/24	3.58MB	Share
1AD	Final Director's Interest Notice (RP)		21/11/24	264.47KB	Share
1AD	Initial Director's Interest Notice X 2 (MB & IR)		21/11/24	248.93KB	Share
1AD	Results of Meeting		20/11/24	188.57KB	Share
1AD	Chair address and CEO presentation to AGM		20/11/24	2.62MB	Share
1AD	Board changes		18/11/24	187.44KB	Share
1AD	Change in substantial holding		05/11/24	152.79KB	Share
1AD	Cleansing Notice under Section 708A		04/11/24	173.92KB	Share
1AD	Application for quotation of securities - 1AD		04/11/24	15.78KB	Share
1AD	ASX Gems Investor Presentation		30/10/24	176.64KB	Share
1AD	Quarterly Appendix 4C and Activities Report	PRICE SENSITIVE	24/10/24	303.66KB	Share
1AD	Chief Medical Officer Appointments		23/10/24	188.79KB	Share
1AD	Letter to Shareholders, Notice of AGM & Proxy Form		18/10/24	545.49KB	Share
1AD	AD-214 clinical advisory board	PRICE SENSITIVE	10/10/24	191.27KB	Share
1AD	FY24 RDTI Refund Received $1.77m	PRICE SENSITIVE	04/10/24	192.62KB	Share
1AD	Change of Director's Interest Notice		10/09/24	293.4KB	Share
1AD	Cleansing Notice under Section 708A		05/09/24	215.31KB	Share
1AD	Application for quotation of securities - 1AD		05/09/24	15.79KB	Share
1AD	Transaction, investment facility update	PRICE SENSITIVE	02/09/24	182.57KB	Share
1AD	Proposed issue of securities - 1AD		02/09/24	17.65KB	Share
1AD	Change in substantial holding		30/08/24	204.49KB	Share
1AD	Appendix 4G and Corporate Governance Statement		28/08/24	624.68KB	Share
1AD	Annual Report to shareholders		28/08/24	1.57MB	Share
1AD	Preliminary Final Report	PRICE SENSITIVE	28/08/24	223.16KB	Share
1AD	Investor events and presentation		21/08/24	3.5MB	Share
1AD	Quarterly Appendix 4C and Activities Report	PRICE SENSITIVE	29/07/24	332.72KB	Share
1AD	Results of Meeting		23/07/24	154.61KB	Share
1AD	Notification regarding unquoted securities - 1AD		04/07/24	15.68KB	Share
1AD	Change of registered address		18/06/24	166.89KB	Share
1AD	Investor Webinar Invitations		18/06/24	167.19KB	Share
1AD	Letter to Shareholders, Notice of EGM & Proxy Form		17/06/24	478.64KB	Share
1AD	Change in substantial holding		04/06/24	152.35KB	Share
1AD	$1.9 million raised from exercise of 1ADOA options	PRICE SENSITIVE	03/06/24	197KB	Share
1AD	Application for quotation of securities - 1AD		03/06/24	347.15KB	Share
1AD	Change in substantial holding		03/06/24	209.46KB	Share
1AD	Change in substantial holding		30/05/24	180.38KB	Share
1AD	Application for quotation of securities - 1AD		29/05/24	335.69KB	Share
1AD	Application for quotation of securities - 1AD		21/05/24	15.38KB	Share
1AD	Investor presentation		20/05/24	9.16MB	Share
1AD	Application for quotation of securities - 1AD		14/05/24	15.38KB	Share
1AD	Cellular immunotherapy manufacturer secured - Cell Therapies	PRICE SENSITIVE	13/05/24	195.01KB	Share
1AD	Cleansing Notice under Section 708A		09/05/24	265.33KB	Share

1AD 1AD Investor Presentation
30/07/25		2.24MB	Share
1AD Notification of cessation of securities - 1AD
28/07/25		15.33KB	Share
1AD Quarterly Appendix 4C and Activities Report
23/07/25	PRICE SENSITIVE	454.87KB	Share
1AD Cleansing Notice
11/07/25		326.43KB	Share
1AD Application for quotation of securities - 1AD
11/07/25		15.9KB	Share
1AD Final Director's Interest Notice
02/07/25		3.22KB	Share
1AD Board Change
30/06/25		184.86KB	Share
1AD Change in Director Interest Notice (IR & DF)
13/06/25		316.74KB	Share
1AD Application for quotation of securities - 1AD
13/06/25		16.99KB	Share
1AD Application for quotation of securities - 1AD
13/06/25		16.37KB	Share
1AD Renounceable Rights Issue shortfall placed
13/06/25	PRICE SENSITIVE	230.62KB	Share
1AD Change in Director Interest Notice (TO, PM, IR & DF)
11/06/25		535.75KB	Share
1AD Change in substantial holding
05/06/25		164.28KB	Share
1AD Top 20 Option Holders & Distribution Schedule
04/06/25		85.24KB	Share
1AD Application for quotation of securities - 1AD
04/06/25		16.42KB	Share
1AD Application for quotation of securities - 1AD
04/06/25		17.02KB	Share
1AD Rights Issue raises $1.1million
03/06/25	PRICE SENSITIVE	225.72KB	Share
1AD Notice of change of exercise price of options
28/05/25	PRICE SENSITIVE	290.43KB	Share
1AD New AD-214 publication
22/05/25		273.42KB	Share
1AD Investor webinar invitation
19/05/25		209.2KB	Share
1AD Investor Presentation
07/05/25		2MB	Share
1AD COMMENCEMENT OF RIGHTS TRADING
07/05/25		192.81KB	Share
1AD Update - Proposed issue of securities - 1AD
05/05/25		25.67KB	Share
1AD Letter to Foreign Shareholders
05/05/25		254.87KB	Share
1AD Letter to Optionholders
05/05/25		283.5KB	Share
1AD Target Market Determination
05/05/25		188.07KB	Share
1AD Update - Proposed issue of securities - 1AD
05/05/25		25.52KB	Share
1AD Prospectus
05/05/25	PRICE SENSITIVE	1.02MB	Share
1AD Change of registered address
02/05/25		185.62KB	Share
1AD Proposed issue of securities - 1AD
01/05/25		25.77KB	Share
1AD Renounceable Rights Issue to Raise up to $1.3 million
01/05/25	PRICE SENSITIVE	231.96KB	Share
1AD Quarterly Appendix 4C and Activities Report
01/05/25	PRICE SENSITIVE	284.08KB	Share
1AD Trading Halt
30/04/25	PRICE SENSITIVE	294.32KB	Share
1AD Notification regarding unquoted securities - 1AD
14/04/25		15.53KB	Share
1AD Notification of cessation of securities - 1AD
14/04/25		12.75KB	Share
1AD ASX Emerging Gems presentation
26/03/25		197.05KB	Share
1AD SYNBV invest up to $2m in East to West subsidiary
20/03/25	PRICE SENSITIVE	267.11KB	Share
1AD Cleansing Notice
17/03/25		294.25KB	Share
1AD Application for quotation of securities - 1AD
17/03/25		15.86KB	Share
1AD Investor presentation - Stocks on Track
13/03/25		1.17MB	Share
1AD R&D Tax Incentive advance received
05/03/25	PRICE SENSITIVE	225KB	Share
1AD Company presentation - East-West Biopharma Summit
04/03/25		1.67MB	Share
1AD Cleansing Notice
21/02/25		229.94KB	Share
1AD Application for quotation of securities - 1AD
21/02/25		15.67KB	Share
1AD Half Yearly Report and Accounts
20/02/25	PRICE SENSITIVE	1.53MB	Share
1AD Webinar presentation - East to West cell therapy strategy
11/02/25		754.42KB	Share
1AD Cleansing Notice
07/02/25		155.72KB	Share
1AD Application for quotation of securities - 1AD
07/02/25		15.67KB	Share
1AD Investor Presentation
07/02/25	PRICE SENSITIVE	1.84MB	Share
1AD Investor webinar: East to West cell therapy strategy
06/02/25		198KB	Share
1AD East to West cell therapy strategy update
06/02/25	PRICE SENSITIVE	566.55KB	Share
1AD AdAlta presenting at 3rd ANZ Biologics Festival
04/02/25		2.21MB	Share
1AD Quarterly Appendix 4C and Activities Report
31/01/25	PRICE SENSITIVE	414.13KB	Share
1AD Notification regarding unquoted securities - 1AD
13/01/25		16.05KB	Share
1AD Investor Presentation
10/01/25	PRICE SENSITIVE	2.31MB	Share
1AD Change of Director's Interest Notice (TO)
05/12/24		296.98KB	Share
1AD Notification regarding unquoted securities - 1AD
05/12/24		19.82KB	Share
1AD Presentation at ASCEPT, APFP & APSA Joint Congress
02/12/24		3.73MB	Share
1AD Investor Presentation
21/11/24		3.58MB	Share
1AD Final Director's Interest Notice (RP)
21/11/24		264.47KB	Share
1AD Initial Director's Interest Notice X 2 (MB & IR)
21/11/24		248.93KB	Share
1AD Results of Meeting
20/11/24		188.57KB	Share
1AD Chair address and CEO presentation to AGM
20/11/24		2.62MB	Share
1AD Board changes
18/11/24		187.44KB	Share
1AD Change in substantial holding
05/11/24		152.79KB	Share
1AD Cleansing Notice under Section 708A
04/11/24		173.92KB	Share
1AD Application for quotation of securities - 1AD
04/11/24		15.78KB	Share
1AD ASX Gems Investor Presentation
30/10/24		176.64KB	Share
1AD Quarterly Appendix 4C and Activities Report
24/10/24	PRICE SENSITIVE	303.66KB	Share
1AD Chief Medical Officer Appointments
23/10/24		188.79KB	Share
1AD Letter to Shareholders, Notice of AGM & Proxy Form
18/10/24		545.49KB	Share
1AD AD-214 clinical advisory board
10/10/24	PRICE SENSITIVE	191.27KB	Share
1AD FY24 RDTI Refund Received $1.77m
04/10/24	PRICE SENSITIVE	192.62KB	Share
1AD Change of Director's Interest Notice
10/09/24		293.4KB	Share
1AD Cleansing Notice under Section 708A
05/09/24		215.31KB	Share
1AD Application for quotation of securities - 1AD
05/09/24		15.79KB	Share
1AD Transaction, investment facility update
02/09/24	PRICE SENSITIVE	182.57KB	Share
1AD Proposed issue of securities - 1AD
02/09/24		17.65KB	Share
1AD Change in substantial holding
30/08/24		204.49KB	Share
1AD Appendix 4G and Corporate Governance Statement
28/08/24		624.68KB	Share
1AD Annual Report to shareholders
28/08/24		1.57MB	Share
1AD Preliminary Final Report
28/08/24	PRICE SENSITIVE	223.16KB	Share
1AD Investor events and presentation
21/08/24		3.5MB	Share
1AD Quarterly Appendix 4C and Activities Report
29/07/24	PRICE SENSITIVE	332.72KB	Share
1AD Results of Meeting
23/07/24		154.61KB	Share
1AD Notification regarding unquoted securities - 1AD
04/07/24		15.68KB	Share
1AD Change of registered address
18/06/24		166.89KB	Share
1AD Investor Webinar Invitations
18/06/24		167.19KB	Share
1AD Letter to Shareholders, Notice of EGM & Proxy Form
17/06/24		478.64KB	Share
1AD Change in substantial holding
04/06/24		152.35KB	Share
1AD $1.9 million raised from exercise of 1ADOA options
03/06/24	PRICE SENSITIVE	197KB	Share
1AD Application for quotation of securities - 1AD
03/06/24		347.15KB	Share
1AD Change in substantial holding
03/06/24		209.46KB	Share
1AD Change in substantial holding
30/05/24		180.38KB	Share
1AD Application for quotation of securities - 1AD
29/05/24		335.69KB	Share
1AD Application for quotation of securities - 1AD
21/05/24		15.38KB	Share
1AD Investor presentation
20/05/24		9.16MB	Share
1AD Application for quotation of securities - 1AD
14/05/24		15.38KB	Share
1AD Cellular immunotherapy manufacturer secured - Cell Therapies
13/05/24	PRICE SENSITIVE	195.01KB	Share
1AD Cleansing Notice under Section 708A
09/05/24		265.33KB	Share

REFRESH

1 2 3 4 5 6

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 0.3¢		Change 0.000(0.00%)		Mkt cap ! $3.338M

Open	High	Low	Value	Volume
0.3¢	0.3¢	0.3¢	$985	328.3K

Buyers (Bids)

No.	Vol.	Price($)
27	25907277	0.2¢

Sellers (Offers)

Price($)	Vol.	No.
0.3¢	14778468	17

View Market Depth

No.	Vol.	Price($)
27	25907277	0.002
21	54981501	0.001
0	0	0.000
0	0	0.000
0	0	0.000

Price($)	Vol.	No.
0.003	14778468	17
0.004	13413960	14
0.005	755195	3
0.006	1963830	1
0.007	111005	1

Last trade - 09.59am 11/08/2025 (20 minute delay)

1AD (ASX) Chart

ADALTA LIMITED - Announcements

Corporate SpotlightNot Yet Available

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories

Corporate Spotlight
Not Yet Available